Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by James Galloway and Mark Yates.
James Galloway
Connection Strength
0.806
Mark Yates
  1. The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know. J Rheumatol. 2021 08; 48(8):1201-1204.
    View in: PubMed
    Score: 0.237
  2. IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression. J Infect. 2021 05; 82(5):178-185.
    View in: PubMed
    Score: 0.234
  3. A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study. J Infect. 2020 08; 81(2):282-288.
    View in: PubMed
    Score: 0.221
  4. COVID-19: opacification score is higher in the right lung and right lung involvement is a better predictor of ICU admission. Eur Respir J. 2020 12; 56(6).
    View in: PubMed
    Score: 0.057
  5. How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis. BMJ Open. 2020 10 05; 10(10):e044566.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.